William Blair Increases Earnings Estimates for Genmab A/S
Genmab A/S (NASDAQ:GMAB – Free Report) – William Blair upped their FY2028 EPS estimates for Genmab A/S in a research note issued on Monday, March 10th. William Blair analyst M. Phipps now forecasts that the company will post earnings per share of $4.06 for the year, up from their previous estimate of $4.02. William Blair […]
